A controlled, double-blind study of haloperidol in 30 children suffering from severe emotional disorders was attempted. Toxic and side-effects and reduction of symptoms were observed over a prolonged period of medication. A battery of tests was designed to study any adverse effects on development and learning processes. The conclusions reached indicated that at an overall level and in terms of diagnostic categories, no statistical significance was established when compared with placebo. However, haloperidol is significantly superior to placebo in ameliorating particular symptoms, is a relatively safe drug, and it did not impair intellectual functioning and learning tasks.
References
1.
BarkerP.FraserI. A. (1968). A controlled trial of haloperidol in children. Brit. J. Psychiat., 114: 855.
2.
CunninghamM. A.PillaiV.RogersW. J. B. (1968). Haloperidol in the treatment of children with severe behaviour disorders. Brit. J. Psychiat., 114: 845.
3.
FishB. (1960). Drug therapy in child psychiatry: pharmacological aspects. Comprehen. Psychiat., 1: 212.
4.
FishB. (1968). Drug use in psychiatric disorders of children. Amer. J. Psychiat., Supplement (February).
5.
FishB. (1969). Problems of diagnosis and the definition of comparable groups: a neglected issue in drug research with children. Amer. J. Psychiat., 125: 900.
6.
G. A. P. (1966). Psychopathological Disorders in Childhood: Theoretical Considerations and a Proposed Classification. Group for the Advancement of Psychiatry, No 662, New York.
7.
GuilfordJ. P. (1956). Fundamental Statistics in Psychology and Education. McGraw-Hill, New York.
8.
KraftI. A. (1968). The use of psychoactive drugs in the out-patient treatment of psychiatric disorders of children. Amer. J. Psychiat., 124: 1401.
9.
National Health and Medical Research Council (1969). Modern Psychotropic Drugs in Medical Practice. N.H.M.R.C., Canberra.
